Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: An angiographic substudy of the ASSENT-4 PCI (assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention) trial

Journal of the American College of Cardiology

Volumn 57, Issue 19, 2011, Pages 1867-1873

  Zalewski, Jaroslaw ^a   Bogaerts, Kris ^b,g   Desmet, Walter ^a   Sinnaeve, Peter ^a   Berger, Peter ^c   Grines, Cindy ^d   Danays, Thierry ^e   Armstrong, Paul ^f   Van De Werf, Frans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KU LEUVEN   (Belgium)

^c GEISINGER MEDICAL CENTER   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e BOEHRINGER INGELHEIM   (France)

^f UNIVERSITY OF ALBERTA   (Canada)

^g HASSELT UNIVERSITY   (Belgium)

Author keywords

facilitated percutaneous coronary intervention; primary percutaneous coronary intervention; ST segment elevation myocardial infarction; thrombus

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TENECTEPLASE; TICLOPIDINE;

ADULT; ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON EMBOLIZATION; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY STENT; CORRELATIONAL STUDY; DISEASE SEVERITY; FACILITATED PERCUTANEOUS CORONARY INTERVENTION; FEMALE; HEART MUSCLE BLOOD FLOW; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; FEMALE; HEART DISEASES; HEPARIN; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 79955606589     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.10.061     Document Type: Article

References (16)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
2. C.P. Cannon, C.M. Gibson, and C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947 (Pubitemid 30414505)
3. S.G. Ellis, M. Tendera, M.A. de Belder FINESSE Investigators Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217 (Pubitemid 351724450)
4. J.P. Collet, G. Montalescot, M. Le May, M. Borentain, and A. Gershlick Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy J Am Coll Cardiol 48 2006 1326 1335 (Pubitemid 44436802)
5. J.P. Henriques, F. Zijlstra, and J.P. Ottervanger Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction Eur Heart J 23 2002 1112 1117 (Pubitemid 35230716)
6. K.C. Wu, E.A. Zerhouni, and R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772 (Pubitemid 28135339)
7. G.W. Stone, M.A. Peterson, A.J. Lansky, G. Dangas, R. Mehran, and M.B. Leon Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J Am Coll Cardiol 39 2002 591 597 (Pubitemid 34158153)
8. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial Lancet 367 2006 569 578
9. The TIMI IIIA Investigators Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) trial Circulation 87 1993 38 52
10. The TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial N Engl J Med 312 1993 932 936
11. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888 (Pubitemid 26074824)
12. M.A. McDonald, Y. Fu, U. Zeymer ASSENT-4 PCI Investigators Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy Eur Heart J 29 2008 871 879 (Pubitemid 351499495)
13. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Lancet 354 1999 716 722
14. F. Beygui, J.-P. Collet, C. Nagaswami, J.W. Weisel, and G. Montalescot Architecture of intracoronary thrombi in ST-elevation acute myocardial infarction Time makes the difference Circulation 113 2006 e21 e23
15. K.J. Harjai, C. Grines, and G.W. Stone Frequency, determinants, and clinical implications of residual intracoronary thrombus following primary angioplasty for acute myocardial infarction Am J Cardiol 92 2003 377 382 (Pubitemid 36959871)
16. H.J. Rapold Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation Lancet 335 1990 481 482 (Pubitemid 20054705)